Faeth Therapeutics, Inc.

NASDAQ: FTH · Healthcare · Biotechnology

PublicHQ Rockville, MD · MontgomeryCIK 0001829802Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 49DQ —GM —SS 51

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, market scale · ↓ filing timeliness, return on equity

Methodology →

Revenue TTM

-$4.9M

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$21.1M

Employees

Market cap

$30.8M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$21.1M-$21.1M2025

Operating income-$22.3M-$22.3M2025

Total assets$22.9M$22.9M2025

Liabilities$4.3M$4.3M2025

Equity$18.6M$18.6M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Faeth Therapeutics, Inc. earned -$21.1M in FY2025 net income.

Peers · Healthcare

Actinium Pharmaceuticals, Inc.28D Kyntra Bio, Inc.61C Lisata Therapeutics, Inc.40D Accuray Incorporated68B

Neighbors

Montgomery →

Lockheed Martin Corporation$75.0B81B+Marriott International, Inc.$26.2B81B+United Therapeutics Corporation$3.2B92A Host Hotels & Resorts, Inc.$6.1B68B AGNC Investment Corp.——ESAB Corporation$2.8B60C

Key facts

CEOAnand Parikh

SectorHealthcare

IndustryBiotechnology

HeadquartersRockville, MD

ExchangeNASDAQ: FTH

Employees29

IPO date2014-08-11

Latest filings

8-K2026-06-18 8-K2026-06-15 8-K2026-06-10 8-K2026-05-22 8-K2026-05-21 8-K2026-05-15 10-Q2026-05-15 DEF 14A2026-04-27

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.